Globus Medical's SWOT analysis: stock outlook amid acquisition and FDA warning
Globus Medical Inc. (NYSE:GMED), a leading medical device company specializing in musculoskeletal disorders, has been making waves in the healthcare sector with its recent acquisition of Nevro Corp ...
Globus Medical (NYSE:GMED) Upgraded at StockNews.com
StockNews.com upgraded shares of Globus Medical (NYSE:GMED – Free Report) from a hold rating to a buy rating in a research ...
Globus Medical: Some Caution After Its Deal For Nevro
Globus Medical started 2025 on a solid note, but a deal for loss-making Nevro creates some discomfort among investors. Read ...
ETF Daily News3d
Globus Medical (NYSE:GMED) Stock Rating Upgraded by StockNews.com
and regenerative biologic products comprising of allografts and synthetic alternatives. Receive News & Ratings for Globus Medical Daily - Enter your email address below to receive a concise daily ...
Business Insider12d
Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients
“We are thrilled to join Globus Medical as this will allow us to reach more patients globally with clinically proven, innovative products that significantly reduce the burden of chronic pain ...
Nasdaq12d
Analyst Expectations For Globus Medical's Future
Get to Know Globus Medical Better Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers.
Yahoo Finance6d
Globus Medical Inks $250M Deal to Acquire Nevro: Stock to Gain?
Globus Medical GMED has entered into a definitive agreement to acquire Nevro Corp. NVRO in an all-cash transaction valued at approximately $250 million. Under the terms of the agreement ...
Nasdaq12d
Globus Medical to Acquire Nevro Corp. in All-Cash Transaction Valued at $250 Million
“We are thrilled to join Globus Medical as this will allow us to reach more patients globally with clinically proven, innovative products that significantly reduce the burden of chronic pain ...